Drug interactions
Ethinylestradiol + Metformin-repaglinide
Severity: Minor
Ethinylestradiol and Metformin-repaglinide: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Ethinylestradiol can modestly impair glucose tolerance and insulin sensitivity, which may reduce the effect of antidiabetic drugs. The effect is usually small with low-dose products.
What this interaction means in plain words
Ethinylestradiol and Metformin-repaglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Pharmacodynamic antagonism through estrogen effects on insulin sensitivity.
What to do
Monitor glycemic control after starting or stopping the estrogen and adjust antidiabetic doses if needed.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Ethinylestradiol and Metformin-repaglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Metformin-repaglinide
Frequently asked questions
Can I take Ethinylestradiol with Metformin-repaglinide?
MediHelp rates the interaction as minor. Ethinylestradiol and Metformin-repaglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ethinylestradiol can modestly impair glucose tolerance and insulin sensitivity, which may reduce the effect of antidiabetic drugs. The effect is usually small with low-dose products.
How serious is the interaction between Ethinylestradiol and Metformin-repaglinide?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor glycemic control after starting or stopping the estrogen and adjust antidiabetic doses if needed.
What other medicines interact with Metformin-repaglinide?
MediHelp also lists interactions of Metformin-repaglinide with, for example, Gemfibrozil, Apalutamide, Clarithromycin. The full list is on the Metformin-repaglinide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
